Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merrilee Needham

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Neuromuscular Disorders : NMD|December 7, 2007
Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisalMerrilee Needham, Amanda Hooper, Ian James, et al.
Respirology Case Reports|April 18, 2022
Isolated diaphragm weakness and the diagnostic value of phrenic nerve stimulationSarbroop Dhillon, Prarthana Abeyweera, Christopher Kosky, et al.
Journal of Neuroimmunology|May 6, 2011
Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complexAdrian P Scott, Nigel G Laing, Frank Mastaglia, et al.
International Journal of Experimental Pathology|November 12, 2013
Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouseYue-Bei Luo, Russell D Johnsen, Lisa Griffiths, et al.
Neuromuscular Disorders : NMD|March 26, 2010
Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findingsKishore R Kumar, Merrilee Needham, Kym Mina, et al.
Neuromuscular Disorders : NMD|May 19, 2020
Is it Pompe Disease? Australian diagnostic considerationsMichel Tchan, Robert Henderson, Andrew Kornberg, et al.
Muscle & Nerve|October 10, 2022
Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosisAndrew Hannaford, Karen Byth, Nathan Pavey, et al.
Human Molecular Genetics|June 28, 2025
Novel missense variants in CFL2 affect F-actin depolymerisation and expand the disease spectrum of CFL2-related myopathyLein N H Dofash, Chiara Folland, Jason Dyke, et al.
Burns : Journal of the International Society for Burn Injuries|May 15, 2026
Characterising manual dexterity, motor cortex neuroplasticity, and intracortical inhibition long after burn injuryGrant S Rowe, Alecia Wood, Mark Fear, et al.
BMJ Neurology Open|May 5, 2023
Modelling accessibility of adult neurology care in Australia, 2020-2034Steve Simpson-Yap, Federico Frascoli, Lucinda Harrison, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Neuromuscular Disorders : NMD|December 7, 2007
Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisalMerrilee Needham, Amanda Hooper, Ian James, et al.
Respirology Case Reports|April 18, 2022
Isolated diaphragm weakness and the diagnostic value of phrenic nerve stimulationSarbroop Dhillon, Prarthana Abeyweera, Christopher Kosky, et al.
Journal of Neuroimmunology|May 6, 2011
Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complexAdrian P Scott, Nigel G Laing, Frank Mastaglia, et al.
International Journal of Experimental Pathology|November 12, 2013
Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouseYue-Bei Luo, Russell D Johnsen, Lisa Griffiths, et al.
Neuromuscular Disorders : NMD|March 26, 2010
Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findingsKishore R Kumar, Merrilee Needham, Kym Mina, et al.
Neuromuscular Disorders : NMD|May 19, 2020
Is it Pompe Disease? Australian diagnostic considerationsMichel Tchan, Robert Henderson, Andrew Kornberg, et al.
Muscle & Nerve|October 10, 2022
Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosisAndrew Hannaford, Karen Byth, Nathan Pavey, et al.
Human Molecular Genetics|June 28, 2025
Novel missense variants in CFL2 affect F-actin depolymerisation and expand the disease spectrum of CFL2-related myopathyLein N H Dofash, Chiara Folland, Jason Dyke, et al.
Burns : Journal of the International Society for Burn Injuries|May 15, 2026
Characterising manual dexterity, motor cortex neuroplasticity, and intracortical inhibition long after burn injuryGrant S Rowe, Alecia Wood, Mark Fear, et al.
BMJ Neurology Open|May 5, 2023
Modelling accessibility of adult neurology care in Australia, 2020-2034Steve Simpson-Yap, Federico Frascoli, Lucinda Harrison, et al.
Pageof 12